Clinical Trials Directory

Trials / Completed

CompletedNCT00323336

Markers of Bone Turnover in Saliva and How This Compares to Urine and Blood

Salivary Markers of Bone Turnover Compared to Urine and Blood

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
Female
Age
25 Years – 70 Years
Healthy volunteers
Accepted

Summary

Study is being done to determine if it is possible to use saliva to measure bone specific proteins and predict bone turnover which could be used in the treatment of osteoporosis.

Detailed description

Prevention and treatment of osteoporosis require sensitive and specific assays of bone turnover. Presently, serum or urinary assessments are used. However, the development of other procedures that are more patient-convenient, non-invasive and cost-efficient would significantly facilitate a clinician's ability to determine bone turnover. The objective of this application is to determine the feasibility of using saliva for this measurement. We will compare serum, urinary and salivary levels in 50 pre- and 50 post-menopausal women. Markers to be measured are bone alkaline phosphatase, osteocalcin, procollagen type propepties hydroxypyridinium crosslinks of collagen and crosslinked collagen telopeptides. Collection of saliva, serum and urine will be done at a single visit. We expect to observe reasonable good correlation between serum and saliva levels and poorer correlation between urine and saliva levels.

Conditions

Timeline

Start date
2006-05-01
Primary completion
2007-11-01
Completion
2007-11-01
First posted
2006-05-09
Last updated
2010-01-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00323336. Inclusion in this directory is not an endorsement.

Markers of Bone Turnover in Saliva and How This Compares to Urine and Blood (NCT00323336) · Clinical Trials Directory